Marshall Wace, LLP Century Therapeutics, Inc. Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.4 - $5.11 $179,581 - $269,899	52,818 Added 91.86%	110,316 $382,000
Q4 2022 Feb 14, 2023	SELL	$4.84 - $11.58 $3.12 Million - $7.46 Million	-643,840 Reduced 91.8%	57,498 $294,000
Q4 2021 Feb 14, 2022	BUY	$13.93 - $23.62 $8.22 Million - $13.9 Million	589,786 Added 528.71%	701,338 $11.1 Million
Q3 2021 Nov 15, 2021	BUY	$20.8 - $31.93 $1.22 Million - $1.88 Million	58,803 Added 111.48%	111,552 $2.81 Million
Q2 2021 Aug 25, 2021	BUY	$22.45 - $29.34 $1.18 Million - $1.55 Million	52,749 New	52,749 $1.55 Million

36.9M

8.7K

10.2K

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $74.2M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.